United States: WilmerHale Counsels Cynosure In $1.65B Acquisition By Hologic
Last Updated: March 1 2017

Cynosure (Nasdaq: CYNO), a developer and manufacturer of aesthetic treatment systems, and Hologic (Nasdaq: HOLX), a developer, manufacturer and supplier of diagnostics, medical imaging and surgical products, today announced the sale of Cynosure to Hologic in a transaction worth approximately $1.65 billion. The transaction is expected to close during late March or April of 2017.

The WilmerHale team on the transaction was led by Hal Leibowitz and Jason Kropp and included Andrew Bonnes, Kim Wethly, Leon Greenfield, Bruce Manheim, Steve Barrett, Laura Schneider, Amy Null, Julie Hogan Rodgers, Ciara Baker, Davis Sluis, Caroline Dotolo and Alex Civetta.

Read the press release for more information.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Press Releases from this Firm
Recent Content from this Firm
By David Gammell
By Jonathan Cedarbaum, D. Reed Freeman, Jr., Alan Schoenfeld, Heather Zachary, Stephanie Simon
By Alan Wilson, Jonathan Wolfman
By Ambassador Charlene Barshefsky, Naboth van den Broek, David Ross, Patrick J. McLain, David Horn
By Frederick Saugman
By Bill Warren
By Michael Connor, H. David Gold, Sarah Judkins, Andrew L. Spielman
By Lester Ross, Tingting Liu
By H. David Gold, Rachel Jacobson, Heidi K. Ruckriegle
By Joseph Mueller, Thomas Saunders, Leslie Pearlson
Font Size: